BIOMERIEUX (EPA:BIM) - bioMérieux receives FDA 510(k) clearance of VIDAS® TBI (GFAP, UCH-L1), an innovative test to improve the assessment of patients with mild traumatic brain injury
Transparency directive : regulatory news
28/05/2024 18:01
source : webdisclosure.com
BIOMERIEUX's latest news
30/10/2024 07:01
15/10/2024 07:01
05/09/2024 07:01
26/06/2024 07:01
21/06/2024 08:35
28/05/2024 18:01
23/05/2024 13:02
09/04/2024 07:15
09/04/2024 07:01
05/04/2024 07:01
Other stories
01/11/2024 01:38
31/10/2024 21:30
31/10/2024 14:21
31/10/2024 22:47
31/10/2024 19:43
31/10/2024 20:35
31/10/2024 21:37
31/10/2024 16:08
31/10/2024 16:32
31/10/2024 23:35
31/10/2024 22:53
31/10/2024 20:16
31/10/2024 14:04
31/10/2024 19:54
31/10/2024 21:56
31/10/2024 12:05
31/10/2024 17:50
31/10/2024 13:18
31/10/2024 17:50
31/10/2024 17:48
31/10/2024 07:27
31/10/2024 18:50
31/10/2024 21:59
31/10/2024 22:38
31/10/2024 20:38
31/10/2024 20:55
Has Nish left EastEnders? Dramatic exit sees actor Navin Chowdhry leave after two years - The Mirror
01/11/2024 01:10
31/10/2024 19:29
31/10/2024 20:44
31/10/2024 22:00
31/10/2024 13:43
31/10/2024 12:15
31/10/2024 08:40
31/10/2024 16:07
31/10/2024 11:44
30/10/2024 16:00
31/10/2024 20:56
31/10/2024 15:44